4-O-[2-(3,5-Dimethyl-4-morpholinyl)-2-oxoethyl]rifamycin(55372-15-1)
- Name: 4-O-[2-(3,5-Dimethyl-4-morpholinyl)-2-oxoethyl]rifamycin
- Synonyms:
- Molecular Formula:C45H60N2O14
- Molecular Weight:852.96
- CAS Registry Number:55372-15-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.55372-15-1 4-O-[2-(3,5-Dimethyl-4-morpholinyl)-2-oxoethyl]rifamycin
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.55372-15-1 4-O-[2-(3,5-Dimethyl-4-morpholinyl)-2-oxoethyl]rifamycin
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.55372-15-1 4-O-[2-(3,5-Dimethyl-4-morpholinyl)-2-oxoethyl]rifamycin
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:4-O-[2-(3,5-Dimethyl-4-morpholinyl)-2-oxoethyl]rifamycin
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 64664-22-8/BAS 40300F
- 180060-52-0/Hexadecanamide,N-[(1S,2R,3E)-2- (benzoyloxy)-1-[[[2,3-di-O-benzoyl-4,6-bis- O-(carboxymethyl)-R-D-galactopyranosyl]oxy]- methyl]-3-heptadecenyl]-,disodium salt
- 14025-27-5/ethyl 4-[(N,N-diethyl-beta-alanyl)amino]-2-hydroxybenzoate hydrochloride (1:1)
- 88092-84-6/chlorodiethoxytitanium
- 152340-71-1/1-Cyclohexene-1-aceticacid,3-(acetyloxy)-6-oxo-4-[(2E,6E,10E)-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl]-,(3R,4R)- (9CI)
- 22242-40-6/6-ethoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 2-phenoxybenzoate hydrobromide (1:1)
- 57334-90-4/Benzamide,5-chloro-N-[2-[4-[[[(cyclohexylamino) carbonyl]amino]sulfonyl]phenyl]- ethyl]-2-hydroxy-
- 182747-60-0/Antimony tin oxide (Sb0.11Sn0.95O2.05)
- 37819-46-8/9,10-dimethoxy-2-(3-methoxybutyl)-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol hydrochloride (1:1)
- 7299-93-6/Butyl ethyl 1,2-benzenedicarboxylate
- 61278-83-9/tricyclo[5.5.0.0~2,8~]dodeca-3,5,9,11-tetraene
- 34695-32-4/3-HYDROXY-3-METHYLGLUTARIC ANHYDRIDE
- 92045-19-7/Gases (petroleum), naphtha steam cracking high-pressure residual
- 5780-16-5/see 1,3-Dithiolan-2-amine,N,N-dimethyl-
- 2883-60-5/3-(Phenethylamino)pyridin-4-amine
- 503605-66-1/Adecatumumab [INN]
- 62596-34-3/Cyclomulberrochromene
- 76250-30-1/(+)-Stegnacin
- 81619-42-3/N-[(4-{[5-chloro-3-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)carbamoyl]-2,6-difluorobenzamide
- 55372-15-1/4-O-[2-(3,5-Dimethyl-4-morpholinyl)-2-oxoethyl]rifamycin
- 32244-96-5/Spirostan-3-one,12-hydroxy-,(5R,12R,25S)-
- 23622-35-7/2H-Tetrazolium,3,3'-[1,1'-biphenyl]-4,4'-diylbis[5-methyl-2-(3-nitrophenyl)-, dichloride (9CI)
- 72371-47-2/(2,4-dimethoxyphenyl)(oxo)acetonitrile
- 10279-60-4/EGYPTIAN BLUE
- 6466-11-1/1,3-dimethyl-2-thioxo-8-(undecylsulfanyl)-1,2,3,7-tetrahydro-6H-purin-6-one
- 68650-47-5/Fatty acids, C18-unsatd, dimers, polymers with N-(6-aminohexyl)-1,6-hexanediamine, ethylenediamine, isophthalic acid and 2-methylpropanoic acid
- 84236-64-6/dibromoplatinum(2+) (1,3-diphenylpropane-1,3-diyl)diazanide
- 158692-23-0/1,3-Benzodioxole-5-acetamide,a-[4-[(2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl]-2-propylphenoxy]-N-[[4-(1-methylethyl)phenyl]sulfonyl]-
- 67232-34-2/H 31866
- 2300-67-6/(2,6-dichloro-4-nitrophenoxy)acetic acid